Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice

Medicine and Dentistry

• Allogenic Bone Marrow Transplantation 100%
• Body Weight 10%
• Bone Marrow 100%
• Bone Marrow Transplantation 30%
• C57BL/6 10%
• Colon 10%
• Conditioning 100%
• Cyclophosphamide 30%
• Enalapril Maleate 10%
• Graft Versus Host Reaction 100%
• Ileum 10%
• Keratinocyte Growth Factor 100%
• Liver 10%
• Lung 10%
• Morbidity 10%
• Mortality 10%
• Observation 10%
• Radiation 10%
• Skin 10%
• Spleen 20%
• Spleen Cell 10%
• Survival 10%
• Survival Rate 10%
• T Cell 10%
• Target Tissue 10%
• Therapeutic Agent 20%
• Tissue Injury 30%
• Tissue Repair 10%
• Whole Body Radiation 30%
• Wound Healing 10%

Immunology and Microbiology

• Body Weight 10%
• Colon 10%
• Conditioning 100%
• Cyclophosphamide 30%
• Dose 10%
• Electric Potential 10%
• Graft-Versus-Host Disease 100%
• Ileum 10%
• Keratinocyte Growth Factor 100%
• Liver 10%
• Lung 10%
• Morbidity 10%
• Mortality 10%
• Mouse 100%
• Murine 10%
• Radiation 10%
• Rodent 10%
• Skin 10%
• Splenocyte 10%
• Survival 10%
• Survival Rate 10%
• T Cell 10%
• Target Tissue 10%
• Tissue Repair 10%
• Tissues 30%
• Transplantation 100%
• Wound Healing 10%